FTXH holdings
First Trust Nasdaq Pharmaceuticals ETF
Positions
51 stored of 51 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ELI LILLY & COMPANY ELI LILLY & COMPANY COM | US5324571083 | 532457108 | 7.767% | $2.8M | Equity (common) | Corporate | United States | USD |
| 2 | ABBVIE INC ABBVIE INC COM | US00287Y1091 | 00287Y109 | 7.387% | $2.7M | Equity (common) | Corporate | United States | USD |
| 3 | MERCK & COMPANY INC MERCK & COMPANY INC COM | US58933Y1055 | 58933Y105 | 7.070% | $2.6M | Equity (common) | Corporate | United States | USD |
| 4 | JOHNSON & JOHNSON JOHNSON & JOHNSON COM | US4781601046 | 478160104 | 6.965% | $2.5M | Equity (common) | Corporate | United States | USD |
| 5 | BRISTOL-MYERS SQUIBB COMPANY BRISTOL-MYERS SQUIBB COMPANY COM | US1101221083 | 110122108 | 6.294% | $2.3M | Equity (common) | Corporate | United States | USD |
| 6 | BIOGEN INC BIOGEN INC COM | US09062X1037 | 09062X103 | 3.837% | $1.4M | Equity (common) | Corporate | United States | USD |
| 7 | VIATRIS INC VIATRIS INC COM | US92556V1061 | 92556V106 | 3.623% | $1.3M | Equity (common) | Corporate | United States | USD |
| 8 | CARDINAL HEALTH INC CARDINAL HEALTH INC COM | US14149Y1082 | 14149Y108 | 3.530% | $1.3M | Equity (common) | Corporate | United States | USD |
| 9 | VERTEX PHARMACEUTICALS INC VERTEX PHARMACEUTICALS INC COM | US92532F1003 | 92532F100 | 3.406% | $1.2M | Equity (common) | Corporate | United States | USD |
| 10 | AMGEN INC AMGEN INC COM | US0311621009 | 031162100 | 3.178% | $1.2M | Equity (common) | Corporate | United States | USD |
| 11 | PFIZER INC PFIZER INC COM | US7170811035 | 717081103 | 2.967% | $1.1M | Equity (common) | Corporate | United States | USD |
| 12 | GILEAD SCIENCES INC GILEAD SCIENCES INC COM | US3755581036 | 375558103 | 2.889% | $1.0M | Equity (common) | Corporate | United States | USD |
| 13 | UNITED THERAPEUTICS CORP UNITED THERAPEUTICS CORP COM | US91307C1027 | 91307C102 | 2.724% | $987K | Equity (common) | Corporate | United States | USD |
| 14 | REGENERON PHARMACEUTICALS INC REGENERON PHARMACEUTICALS INC COM | US75886F1075 | 75886F107 | 2.717% | $985K | Equity (common) | Corporate | United States | USD |
| 15 | JAZZ PHARMACEUTICALS PLC JAZZ PHARMACEUTICALS PLC SHS USD | IE00B4Q5ZN47 | Not reported | 2.487% | $901K | Equity (common) | Corporate | Ireland | USD |
| 16 | INCYTE CORP INCYTE CORP COM | US45337C1027 | 45337C102 | 2.392% | $867K | Equity (common) | Corporate | United States | USD |
| 17 | ILLUMINA INC ILLUMINA INC COM | US4523271090 | 452327109 | 1.983% | $719K | Equity (common) | Corporate | United States | USD |
| 18 | ZOETIS INC ZOETIS INC CL A | US98978V1035 | 98978V103 | 1.867% | $677K | Equity (common) | Corporate | United States | USD |
| 19 | EXELIXIS INC EXELIXIS INC COM | US30161Q1040 | 30161Q104 | 1.725% | $625K | Equity (common) | Corporate | United States | USD |
| 20 | CHARLES RIVER LABORATORIES INTERNATIONAL INC CHARLES RIVER LABORATORIES INTERNATIONAL INC COM | US1598641074 | 159864107 | 1.487% | $539K | Equity (common) | Corporate | United States | USD |
| 21 | MEDPACE HOLDINGS INC MEDPACE HOLDINGS INC COM | US58506Q1094 | 58506Q109 | 1.412% | $512K | Equity (common) | Corporate | United States | USD |
| 22 | PTC THERAPEUTICS INC PTC THERAPEUTICS INC COM | US69366J2006 | 69366J200 | 1.371% | $497K | Equity (common) | Corporate | United States | USD |
| 23 | NEUROCRINE BIOSCIENCES INC NEUROCRINE BIOSCIENCES INC COM | US64125C1099 | 64125C109 | 1.367% | $495K | Equity (common) | Corporate | United States | USD |
| 24 | ALKERMES PLC ALKERMES PLC SHS | IE00B56GVS15 | Not reported | 1.354% | $491K | Equity (common) | Corporate | Ireland | USD |
| 25 | HALOZYME THERAPEUTICS INC HALOZYME THERAPEUTICS INC COM | US40637H1095 | 40637H109 | 1.208% | $438K | Equity (common) | Corporate | United States | USD |
| 26 | BIOMARIN PHARMACEUTICAL INC BIOMARIN PHARMACEUTICAL INC COM | US09061G1013 | 09061G101 | 1.115% | $404K | Equity (common) | Corporate | United States | USD |
| 27 | TWIST BIOSCIENCE CORP TWIST BIOSCIENCE CORP COM | US90184D1000 | 90184D100 | 1.027% | $372K | Equity (common) | Corporate | United States | USD |
| 28 | SPYRE THERAPEUTICS INC SPYRE THERAPEUTICS INC COM NEW | US00773J2024 | 00773J202 | 0.967% | $351K | Equity (common) | Corporate | United States | USD |
| 29 | TRAVERE THERAPEUTICS INC TRAVERE THERAPEUTICS INC COM | US89422G1076 | 89422G107 | 0.893% | $324K | Equity (common) | Corporate | United States | USD |
| 30 | TG THERAPEUTICS INC TG THERAPEUTICS INC COM | US88322Q1085 | 88322Q108 | 0.855% | $310K | Equity (common) | Corporate | United States | USD |
| 31 | ELANCO ANIMAL HEALTH INC ELANCO ANIMAL HEALTH INC COM | US28414H1032 | 28414H103 | 0.829% | $300K | Equity (common) | Corporate | United States | USD |
| 32 | 10X GENOMICS INC 10X GENOMICS INC CL A COM | US88025U1097 | 88025U109 | 0.779% | $282K | Equity (common) | Corporate | United States | USD |
| 33 | GUARDANT HEALTH INC GUARDANT HEALTH INC COM | US40131M1099 | 40131M109 | 0.748% | $271K | Equity (common) | Corporate | United States | USD |
| 34 | LIGAND PHARMACEUTICALS INC LIGAND PHARMACEUTICALS INC COM NEW | US53220K5048 | 53220K504 | 0.747% | $271K | Equity (common) | Corporate | United States | USD |
| 35 | ARCUS BIOSCIENCES INC ARCUS BIOSCIENCES INC COM | US03969F1093 | 03969F109 | 0.709% | $257K | Equity (common) | Corporate | United States | USD |
| 36 | AMNEAL PHARMACEUTICALS INC AMNEAL PHARMACEUTICALS INC COM STK CL A | US03168L1052 | 03168L105 | 0.693% | $251K | Equity (common) | Corporate | United States | USD |
| 37 | ARROWHEAD PHARMACEUTICALS INC ARROWHEAD PHARMACEUTICALS INC COM | US04280A1007 | 04280A100 | 0.656% | $238K | Equity (common) | Corporate | United States | USD |
| 38 | CATALYST PHARMACEUTICALS INC CATALYST PHARMACEUTICALS INC COM | US14888U1016 | 14888U101 | 0.638% | $231K | Equity (common) | Corporate | United States | USD |
| 39 | KRYSTAL BIOTECH INC KRYSTAL BIOTECH INC COM | US5011471027 | 501147102 | 0.632% | $229K | Equity (common) | Corporate | United States | USD |
| 40 | PROTAGONIST THERAPEUTICS INC PROTAGONIST THERAPEUTICS INC COM | US74366E1029 | 74366E102 | 0.624% | $226K | Equity (common) | Corporate | United States | USD |
| 41 | MODERNA INC MODERNA INC COM | US60770K1079 | 60770K107 | 0.613% | $222K | Equity (common) | Corporate | United States | USD |
| 42 | MIRUM PHARMACEUTICALS INC MIRUM PHARMACEUTICALS INC COM | US6047491013 | 604749101 | 0.594% | $215K | Equity (common) | Corporate | United States | USD |
| 43 | KYMERA THERAPEUTICS INC KYMERA THERAPEUTICS INC COM | US5015751044 | 501575104 | 0.588% | $213K | Equity (common) | Corporate | United States | USD |
| 44 | ROIVANT SCIENCES LTD ROIVANT SCIENCES LTD SHS | BMG762791017 | Not reported | 0.573% | $208K | Equity (common) | Corporate | Bermuda | USD |
| 45 | ACADIA PHARMACEUTICALS INC ACADIA PHARMACEUTICALS INC COM | US0042251084 | 004225108 | 0.483% | $175K | Equity (common) | Corporate | United States | USD |
| 46 | IONIS PHARMACEUTICALS INC IONIS PHARMACEUTICALS INC COM | US4622221004 | 462222100 | 0.458% | $166K | Equity (common) | Corporate | United States | USD |
| 47 | ARCUTIS BIOTHERAPEUTICS INC ARCUTIS BIOTHERAPEUTICS INC COM | US03969K1088 | 03969K108 | 0.455% | $165K | Equity (common) | Corporate | United States | USD |
| 48 | ALNYLAM PHARMACEUTICALS INC ALNYLAM PHARMACEUTICALS INC COM | US02043Q1076 | 02043Q107 | 0.424% | $154K | Equity (common) | Corporate | United States | USD |
| 49 | SUPERNUS PHARMACEUTICALS INC SUPERNUS PHARMACEUTICALS INC COM | US8684591089 | 868459108 | 0.398% | $144K | Equity (common) | Corporate | United States | USD |
| 50 | TARSUS PHARMACEUTICALS INC TARSUS PHARMACEUTICALS INC COM | US87650L1035 | 87650L103 | 0.391% | $142K | Equity (common) | Corporate | United States | USD |
| 51 | DREYFUS GOVERNMENT CASH MANAGEMENT FUNDS DREYFUS GOVERNMENT CASH MANAGEMENT FUNDS SH BEN INT | US2620062081 | 262006208 | 0.104% | $38K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |